Kim MJ - Search Results

1

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

Kim MJ, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ. Kim MJ, et al. Among authors: kim dw, kim ty. BMC Cancer. 2008 Dec 18;8:374. doi: 10.1186/1471-2407-8-374. BMC Cancer. 2008. PMID: 19091129 Free PMC article.

2

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.

Kim DW, Oh DY, Shin SH, Kang JH, Cho BC, Chung JS, Kim H, Park KU, Kwon JH, Han JY, Kim MJ, Bang YJ. Kim DW, et al. Among authors: kim h, kim mj. BMC Cancer. 2014 Nov 3;14:795. doi: 10.1186/1471-2407-14-795. BMC Cancer. 2014. PMID: 25362970 Free PMC article. Clinical Trial.

3

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.

Kim MJ, Han SW, Lee DW, Cha Y, Lee KH, Kim TY, Oh DY, Kim SH, Im SA, Bang YJ, Kim TY. Kim MJ, et al. Among authors: kim ty, kim sh. Cancer Res Treat. 2016 Jul;48(3):990-7. doi: 10.4143/crt.2015.296. Epub 2016 Jan 14. Cancer Res Treat. 2016. PMID: 26790967 Free PMC article.

4

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.

Kim MJ, Nam HJ, Kim HP, Han SW, Im SA, Kim TY, Oh DY, Bang YJ. Kim MJ, et al. Among authors: kim ty, kim hp. Cancer Lett. 2013 Jul 10;335(1):145-52. doi: 10.1016/j.canlet.2013.02.010. Epub 2013 Feb 10. Cancer Lett. 2013. PMID: 23402820

5

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors.

Oh DY, Lee SH, Han SW, Kim MJ, Kim TM, Kim TY, Heo DS, Yuasa M, Yanagihara Y, Bang YJ. Oh DY, et al. Among authors: kim ty, kim tm, kim mj. Cancer Res Treat. 2015 Oct;47(4):607-15. doi: 10.4143/crt.2014.249. Epub 2015 Feb 26. Cancer Res Treat. 2015. PMID: 25715763 Free PMC article. Clinical Trial.

6

Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion.

Yoo ES, Lee KE, Seo JW, Yoo EH, Lee MA, Im SA, Mun YC, Lee SN, Huh JW, Kim MJ, Jo DY, Ahn JY, Lee SM, Chung WS, Kim JH, Seong CM. Yoo ES, et al. Among authors: kim mj, kim jh. Stem Cells. 2003;21(2):228-35. doi: 10.1634/stemcells.21-2-228. Stem Cells. 2003. PMID: 12634419

7

A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer.

Park SR, Kim MJ, Nam BH, Kim CG, Lee JY, Cho SJ, Kong SY, Park YI. Park SR, et al. Among authors: kim cg, kim mj. Eur J Cancer. 2017 Sep;83:32-42. doi: 10.1016/j.ejca.2017.06.008. Epub 2017 Jul 14. Eur J Cancer. 2017. PMID: 28711577 Clinical Trial.

8

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.

Kim YW, Kim MJ, Ryu KW, Lim HS, Lee JH, Kong SY, Lee JS, Choi IJ, Kim CG, Lee JY, Cho SJ, Kook MC, Park YI, Kim SK, Park SR. Kim YW, et al. Among authors: kim cg, kim sk, kim mj. Gastric Cancer. 2016 Apr;19(2):586-596. doi: 10.1007/s10120-015-0490-3. Epub 2015 Apr 8. Gastric Cancer. 2016. PMID: 25851942 Clinical Trial.

9

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine.

Lee KW, Kim BJ, Kim MJ, Han HS, Kim JW, Park YI, Park SR. Lee KW, et al. Among authors: kim bj, kim mj, kim jw. Cancer Res Treat. 2017 Jul;49(3):706-716. doi: 10.4143/crt.2016.216. Epub 2016 Oct 18. Cancer Res Treat. 2017. PMID: 27764906 Free PMC article. Clinical Trial.

10

Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer.

Kim JE, Hong YS, Ryu MH, Lee JL, Chang HM, Lim SB, Kim JH, Jang SJ, Kim MJ, Yu CS, Kang YK, Kim JC, Kim TW. Kim JE, et al. Among authors: kim tw, kim jc, kim mj, kim jh. Cancer Sci. 2011 Sep;102(9):1706-11. doi: 10.1111/j.1349-7006.2011.02009.x. Epub 2011 Jul 12. Cancer Sci. 2011. PMID: 21679278 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,216 results

Search Page

Filters